Introduction
Graves' disease (GD) is a complex, organ-specific autoimmune disease wherein the thyroid gland becomes enlarged and overactive (21) . GD is characterized by a variety of clinical features such as hyperthyroidism, diffuse goiter, presence of autoantibodies against thyroid-specific antigens and dermopathy. Results of genetic studies from homozygous twins have revealed the importance of genetic factors in the development of GD and suggest that approximately 80% of GD development is determined by genetic factors (2) . The infiltration of T cells into the thyroid gland is an important feature of GD. The accumulation of T cells in the thyroid gland is considered an important factor in promoting inflammatory responses and tissue remodeling, which worsen the progression of GD (7, 18) . T cells secrete a variety of cytokines, including , that promote inflammation, act as chemoattractants to recruit more inflammatory cells, and activate target cells to enhance the progression of GD (5, 11, 13, 14) .
IL-16, a known T-cell chemoattractant, promotes the migration of T cells to target sites. Several cell types express IL-16, including T cells, eosinophils, dendritic cells, fibroblasts, epithelial cells and neuronal cells (5) . The serum levels of IL-6, IL-1β and tumor necrosis factor (TNF)-α are higher in GD patients than in control subjects (15) . Gianoukakis et al. showed that treating thyrocytes with IL-1β increases chemotactic activities by upregulating the expression levels of IL-16 (8) . In addition, fibroblasts treated with IgG isolated from GD patients also increase the expression level of IL-16 (17) . These studies suggest the importance of IL-16 in the pathogenesis of GD. IL-16 is a CD4-specific ligand required for the initiation of the bioactivities. By binding to the CD4 molecule, IL-16 activates T cells, monocytes, macrophages and dendritic cells, and increases the production of TNF-α, IL-1β and IL-6 leading to inflammatory responses (3, 4, 12) . In GD, T cells infiltrate the thyroid gland and collaborate with thyrocytes and fibroblasts to form a paracrine loop between IL-16 and IL-1β, which maintains the inflammatory responses. This vicious cycle continuously induces inflammatory responses in the thyroid gland and subsequently induces GD.
To determine the genetic role of IL-16 in GD pathogenesis, we investigated single-nucleotide polymorphisms (SNPs) in the IL-16 gene that may be associated with the protection against or risk factors for GD in Taiwan Chinese patients.
Materials and Methods

Patients
A total of 474 patients with GD were enrolled in this study. The diagnosis of GD was performed by endocrinologists and was assessed by ophthalmologists. The diagnosis of GD was made on the basis of clinical symptoms and biochemical affirmation of hyperthyroidism, multinodular goiter and a positive result for at least one of the following biochemical tests: thyroid-stimulating hormone receptor antibody, diffusely increased iodine-131 uptake in the thyroid gland and exophthalmos. Patients with GD were classified in accordance with the NOSPECS system recommended by the American Thyroid Association. Blood samples were collected for genomic DNA isolation and serological tests. This study was approved by the ethical committee and institutional review board of the China Medical University Hospital. Informed consent was obtained from all patients or their guardians.
SNP Genotyping
IL16 SNP genotype information was retrieved from the HapMap database for the HCB + JPT populations. The gene boundary of IL-16 was determined by SNPper program (http://snpper.chip.org) which are -10 kb from the transcription start site and +10 kb from the stop codon. Tagging SNPs were selected through the Tagger function in the Haploview software program (version 4.2). The selection criteria were: [1] the minor allele frequency should be greater than 10%; [2] SNPs that potentially affect transcription efficiency, translation efficacy or protein functions were selected first; and [3] the availability of probes or primers that passed the manufacturer's qualification requirements (Applied Biosystems Inc., Foster City, CA, USA). We used aggressive tagging method which use 2-and 3-marker haplotypes and set a maximum of 8 tags. We forced to include rs4072111 which may influence the splicing efficiency. The rest of the SNPs were determined by the Haploview software. Eight polymorphisms were selected according to these criteria: rs7182786 (A/G), rs8028364 (C/G), rs12907134 (A/G), rs4128767 (A/G), rs4072111 (A/G), rs8031107 (A/G), rs4072680 (A/G) and rs1131445 (A/G).
Statistical Analysis
PLINK (v. 1.07; http://pngu.mgh.harvard.edu/ ~purcell/plink/) was used for the analysis of the genotype frequency and allelic frequency distributions of the polymorphisms in controls and patients with GD. Hardy-Weinberg equilibrium (HWE) was performed separately for controls and GD patients. Haplotype analysis with sliding windows were analyzed with PLINK. Haplotype blocks were created with Haploview (http://www.broadinstitute.org/ scientific-community/science/programs/medicaland-population-genetics/haploview/haploview). A P-value less than 0.05 was considered statistically significant. The odds ratio (OR) was calculated from genotype frequencies and allelic frequencies with a 95% confidence interval (CI).
Results
Eight SNPs were examined; these were designated S1 to S8 in sequential order from the 5′-end of the IL-16 gene for easy reference (Table 1 ). All SNPs were in Hardy-Weinberg equilibrium. The genotype 01 Allelic The SNPs are designated as S1 to S8 for easy reference and discussion. The two alleles of each SNPs are assigned as "1" or "2" and the genotypes counts are the exact numbers of genotypes 11, 12 and 22 in either the GD patients or control individuals. HWE stands for Hardy-Weinberg equilibrium. The association analysis was performed using five different models for each SNP: genotypic (Geno), additive (Add), dominant (Dom), recessive (Rec) and allelic models. The most significant results are shown in this table. and allele distributions of the 8 polymorphisms are shown in Table 1 . Five different genetic models (genotypic, additive, dominant, recessive and allelic) were used to determine the difference between the healthy population of Han Chinese in Beijing (HCB) (obtained from the PubMed SNP database) and GD patients.
Comparison of the genotypes and allele frequencies between the control subjects and GD patients showed no significant differences in 6 of the 8 polymorphisms, including S1, S3, S4, S5, S6 and S7 (Table 1) ; however, significant differences were found for S2 and S8. The lowest P-values among the 5 different genetic models were observed in the genotypic model for S2 (P = 2.93 × 10 -17
) and the allelic model for S8 (P = 0.01) ( Table 1 ). The 8 SNPs were then subjected to a linkage disequilibrium (LD) plot by using the Haploview program. The D′ and r 2 values are presented as diamond-shaped points on the graph (Fig. 1) . The LD map showed distinct differences between the 2 groups; an apparent variation in the S2 polymorphism was detected, indicating that this SNP may play some role in developing GD (Fig. 1) .
The selected 8 SNPs (S1 to S8) are regarded as evolutionarily stable because no significant differences were found between HCB and Japanese in Tokyo, Japan (JPT). For S2 and S8, we did not detect significant differences between HCB and a more distant population of Yoruba in Ibadan, Nigeria (YRI) (P = 0.34 and 0.09, respectively), indicating they are stable between different ethnic groups ( Table 2) .
The CG and CC genotypes at S2 had a 0.2-and 0.03-fold lower risk of developing GD, respectively. The C allele in S2 showed a protective role in GD development and was 0.17-fold lower than the G allele. The G allele at S8 showed a 1.97-fold increase in risk for the development of GD compared with the A allele (Table 3) . Taken together, these results showed a significant difference between the control groups and GD patients with regard to genotype or allele distribution for the S2 polymorphism. Furthermore, the frequency of the C allele was significantly lower in GD patients.
Haplotype frequencies were estimated among the 8 polymorphisms. The haplotypes were determined using a sliding-window approach and were examined in haplotypes of all possible sizes (Table 4) . We used 36 sliding windows in all, and 14 of these were significantly associated with GD (omnibus test P < 0.05). For sliding windows with a size of up to 3 SNPs per window, the omnibus test result was significant when S2 was included in the window. The importance of S2 was more obvious when the sliding windows at 6 SNPs per window showed the significant results. The relative importance of SNPs within a sliding window was less apparent when the SNPs increased beyond 6 SNPs per window ( Table 4 ). The details of haplotype analysis for the 6-SNP window are shown in Table  5 . We found 2 protective haplotypes: GCAAGG (P = 8.69 × 10 
Discussion
In this study, we investigated the role of IL-16 polymorphisms in the risk of GD pathogenesis. Among the eight tagSNPs tested, rs8028364 and rs1131445 showed significant association with GD. Moreover, haplotype analysis showed that GCAAGG and AGAAGG played a protective role, whereas GGGGAA and GGGAGA were risk factors for GD.
In the study of the association between IL-16 polymorphisms with GD, Gu et al. found that the IL-16 polymorphisms were associated with GD as well as The lowest P-values of overall haplotype distribution (omnibus) is shown in boldface.
Graves' ophthalmopathy (GO) (9) . However, we did not find any association between IL-16 polymorphisms with GO. There are two possible explanations for the discrepancies: [1] we did not include in our study rs4778889 and rs4778641 which are the two significant SNPs in the study of Gu et al.; [2] it is not possible to get two exactly the same clinical samples with the same genetic background often resulting in different association datasets. The potential biological functions of the SNPs tested in this study were predicted through the website: http://snpinfo.niehs.nih.gov/snpfunc.htm. The website predicts the following potential biological functions: transcription factor binding site, non-synonymous coding SNPs, stop codon, damaging SNPs, splicing regulation and microRNA (miRNA) binding site. No potential influences on the biological functions of S1, S2, S3, S4 and S7 were found. For S5 (rs4072111) and S6 (rs8031107), the results show S5 and S6 to be exonic splicing enhancers (ESEs) that influence mRNA transcription.
Exons in mammalian cells generally comprise only a fraction of the length of a pre-mRNA transcript. Accurate splicing requires the identification of shorter exonic sequences from lengthy intronic sequences. This identification is achieved by the binding of spliceosomal components to intronic and exonic splicing sequence elements. These short sequences can either enhance (ESEs) or reduce (exonic splicing silencers or ESSs) splicing at a nearby splice site (10, 20) . The presence of a higher density of ESEs in authentic exons than in pseudo-exons may contribute to the recognition of the correct exons, whereas the presence of ESSs in pseudo-exons may suppress their splicing (6, 16 An exhaustive haplotype analysis of all potential window sizes (sliding-window strategy) was performed to identify the most appropriate and significant associations between GD patients and the control subjects. The results show that there is at least 1 haplotype significantly associated with GD (Table 4 ). The 6-SNP window, consisting of rs7182786 (S1), rs8028364 (S2), rs12907134 (S3), rs4128767 (S4), rs4072111 (S5) and rs8031107 (S6) shows the most significant association with GD (P = 2.3 × 10 -51 ). Among the SNPs, S3 and S6 seem to play important roles in determining whether the haplotypes are a risk or protective haplotype. GC There are some drawbacks in our studies. First, the sample size of the control groups was small. Second, although we did re-genotype all the patient samples on rs8028364 and confirmed the genotype and allele frequencies, one may still speculate the possibility of mis-typing the genotype CC to GG or GG to CC. Moreover, we did not determine the IL-16 concentrations in the GD sera. An extended study is currently being conducted to remedy the above drawbacks. 31) The odds ratios (OR) are shown in boldface when their corresponding haplotypes are significantly associated with GD (P < 0.05). Only haplotypes with a frequency of 0.02 or above in either cases or controls are shown. PLINK calculates OR for a particular haplotype with reference to all the other haplotypes, and hence the reference haplotypes are different for different individual haplotypes under study.
In conclusion, the results of the present study suggest that the IL-16 genotypes and haplotypes may be associated with GD. This report provides evidence that polymorphisms of the IL-16 gene provide insight into the prediction of GD.
